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Tyrosinase, the rate-limiting enzyme for melanin
synthesis, is induced after ultraviolet irradiation as
part of the tanning response, the major recognized
photoprotective response of human skin. Other
DNA-damaging agents and DNA fragments such as
thymidine dinucleotides also induce tyrosinase gene
expression. Moreover, like ultraviolet light they also
activate p53. To determine whether p53 activation is
required for this increased tyrosinase expression, we
employed two experimental systems: (i) a human
melanoma line (WM35) known to express wild-type
p53 versus WM35 cells engineered to express a tran-
scriptionally inactive dominant-negative p53 (WM35-
p53DN) or the empty vector alone (WM35-pCMV7)
and (ii) mice with wild-type p53 versus p53 knockout
mice. In WM35-p53DN cells, the baseline p53 protein
level was higher than in WM35 or WM35-pCMV7
cells, and tyrosinase transcripts were lower. After
ultraviolet irradiation, in all cell lines the p53 protein
level increased within the ®rst 24 h, as expected; and
at 24 h tyrosinase mRNA levels were decreased.
Consistent with the literature, these data in com-
bination suggest that increased p53 protein level
downregulates tyrosinase mRNA. In WM35 and
WM35-pCMV7 cells at 48 and 72 h, however,
whereas p53 levels remained elevated, tyrosinase
mRNA levels compared to pre-irradiation levels
tripled, whereas in WM35-p53DN cells levels
remained below baseline. In thymidine-dinucleotide-
treated WM35 and WM35-pCMV7 cells there was a
comparable upregulation of tyrosinase mRNA within
24 h that persisted through 72 h, but there was no
upregulation of tyrosinase mRNA in WM35-p53DN
cells any time after ultraviolet irradiation or thymi-
dine dinucleotide treatment. In ear skin of p53
wild-type mice, topical application of thymidine
dinucleotide induced a 4±5-fold increase in epider-
mal melanin content after 3 wk, but in p53 knockout
mice thymidine dinucleotide application caused no
detectable increase in melanin. Together, these data
demonstrate that p53 activation increases tyrosinase
mRNA level and subsequently pigmentation. The
data further suggest that tanning is part of a
p53-mediated adaptive response of mammalian skin
to DNA damage from ultraviolet irradiation. Key
words: melanogenesis/photoprotection/pigmentation. J
Invest Dermatol 118:126±132, 2002
T
yrosinase is the rate-limiting enzyme for melanin
biosynthesis (Hearing and JimeÂnez, 1989), the process
that largely determines skin color. Tyrosinase gene
transcription and enzyme activity are known to be
regulated by a number of hormonal, environmental,
and pharmacologic agents (Halaban et al, 1984; Fuller et al, 1987;
Friedmann and Gilchrest, 1987; Ranson et al, 1988; Bolognia et al,
1989; Gordon and Gilchrest, 1989; Abdel-Malek et al, 1995; Eller
et al, 1996; Gilchrest et al, 1998), and at least two second messenger
systems are involved in melanin biosynthesis: protein kinase C
(Gordon and Gilchrest, 1989; Park et al, 1993; 1999; Allan et al,
1995) and the cyclic adenosine monophosphate (cAMP)±protein
kinase A pathway (Pawelek et al, 1975; Wong and Pawelek, 1975;
Halaban et al, 1984).
Tanning or ultraviolet (UV) induced melanogenesis is a familiar
photoprotective response of human skin in which epidermal
melanin content gradually increases over several days following a
suf®cient sun exposure, rendering the skin more resistant to
subsequent UV damage (McGregor and Hawk, 1999). Although
UV effects on skin are multiple and complex (McGregor and
Hawk, 1999), considerable evidence implicates DNA damage or its
repair in stimulating tanning (Eller et al, 1996; Gilchrest et al, 1998;
Gilchrest and Eller, 1999). For example, treatment of UV-
irradiated pigment cells with T4 endonuclease V, an enzyme
known to mediate the ®rst and rate limiting step in repairing
thymine dimers and not known to have any other activity,
enhances their tanning response to the UV irradiation (Gilchrest et
al, 1993). Moreover, melanogenesis is enhanced by treatment of
skin and skin-derived cells with small DNA oligonucleotides such
as thymidine dinucleotides (pTpT), known to enter the nucleus
(Hadshiew et al, 2001) and presumed to mimic UV-damaged DNA
(Eller et al, 1994; 1996; Gilchrest and Eller, 1999). Melanogenesis is
enhanced also by agents such as UV-mimetic chemotherapeutic
drugs and DNA restriction enzymes known speci®cally to damage
DNA (Eller et al, 1996). Interestingly, all these agents also
upregulate and activate the p53 tumor suppresser protein (Hupp
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et al, 1992; Lane, 1992; Lu and Lane, 1993; Zhan et al, 1993; Eller et
al, 1997; Goukassian et al, 1999; Maeda et al, 1999), leading to
increased DNA binding and transcription of genes whose promoter
contains a p53 consensus sequence.
Kichina et al (1996) demonstrated that stable transfection of wild-
type p53 into a pigmented melanoma line leads to overexpression
of wild-type p53 associated with a decrease in the level of tyrosinase
mRNA and tyrosinase activity. By transient cotransfection of a
p53-expressing plasmid and a chloramphenicol acetyl transferase
(CAT) reporter gene linked to a tyrosinase promoter, these authors
showed that increasing p53 protein levels speci®cally repressed
CAT gene expression by the tyrosinase promoter, but in this study
the p53 activity status was not addressed. Preliminary data from our
laboratory1 suggested a role for p53 activation in upregulating
tyrosinase expression, however, and more recently Nylander et al
(2000) reported activation of a tyrosinase promoter construct in the
p53-null human osteosarcoma cell line Saos-2 transfected with a
wild-type p53 expression vector, under conditions in which p53
activation was demonstrated using yet another promotor construct.
Although they mapped a p53-regulated transcriptional control
element near the translation start site of the tyrosinase gene, it was
not determined whether p53 directly or indirectly interacts with
this site to affect tyrosinase transcription. Moreover, using a cell line
of nonmelanocytic origin leaves open the possibility that the
observed upregulation of the transfected tyrosinase promoter
construct resulted from p53 acting on one or more genes not
expressed in melanocytes, thus creating an artifactual connection
between p53 and tyrosinase expression.
p53 is a nuclear phosphoprotein that functions as a transcription
factor (Farmer et al, 1992; Fields and Jang, 1992) and has been
shown to directly activate transcription of several genes such as
those encoding the growth-arrest and DNA-damage-inducible
protein 45 (GADD45) (Kastan et al, 1992), the 21 kDa protein
(p21/WAF1) (el-Deiry et al, 1993), and murine double-minute 2
protein (Wu et al, 1993). p53 has also been shown to negatively
regulate the promoters of some genes including those encoding Fos
(Kley et al, 1992), Myc (Moberg et al, 1992), interleukin-6
(Santhanam et al, 1991), proliferating cell nuclear antigen
(Yamaguchi et al, 1994; Shivakumar et al, 1995; Morris et al,
1996), multiple drug resistance 1 (Li et al, 1997), retinoblastoma
protein (Martin et al, 1993; Rolley et al, 1995), and heat-shock
protein 70 (Agoff et al, 1993). These ®ndings indicate that p53 can
act as either a transcriptional activator or repressor.
Recent work from our laboratory has shown that the small DNA
dinucleotide pTpT upregulates and activates p53 as shown by
nuclear translocation and enhanced binding of p53 to its consensus
sequence DNA (Eller et al, 1997; Goukassian et al, 1999) as well as
by increased transcription of a human growth hormone gene under
control of a p53-regulated promoter (Maeda et al, 1999). Also, the
genes encoding GADD45, excision-repair cross-complementing 3
(ERCC3), and p21, known to be transcriptionally activated by p53,
have been shown to be upregulated by pTpT (Eller et al, 1997;
Goukassian et al, 1999). Moreover, northern blot analysis of p53-
null versus p53-transfected cells demonstrated that p21 upregulation
by pTpT requires p53 (Eller et al, 1997). As noted above, tyrosinase
gene expression is also induced by treatment of melanocytic cells
with pTpT (Eller et al, 1994; 1996).
To further elucidate the impact of p53 protein level and activity
on tyrosinase expression, we ®rst examined the expression of
tyrosinase mRNA in a wild-type p53-expressing melanoma cell
line derived from an early primary tumor (WM35), in a cell line
derived from WM35 stably transfected to constitutively express a
transcriptionally dominant-negative p53 (WM35-p53DN) and in
WM35 cells transfected with the plasmid vector alone (WM35-
pCMV7) as a control. We present evidence that the tyrosinase gene
is regulated by p53 in a dual manner, with p53 protein level
negatively regulating tyrosinase transcription, as previously reported
(Kichina et al, 1996), and activation of p53 increasing tyrosinase
mRNA expression. To further con®rm the requirement for p53 in
pTpT-induced pigmentation in intact skin, p53 knockout mice
were compared to p53 wild-type controls in their ability to respond
to topical application of pTpT. Only animals with wild-type p53
increased their epidermal melanin content.
MATERIALS AND METHODS
Cell lines and culture conditions WM35 cells were derived from an
early, radial growth phase primary melanoma (Cornil et al, 1991;
Florenes et al, 1996). These cells contain wild-type p53 and express the
protein at a low but detectable level. Mutant p53 cDNA was generated
by substitution of a single nucleotide (C to T) at codon 143 resulting in
a change of valine to alanine, creating an inactive dominant-negative
protein (Baker et al, 1990). This cDNA in the pCMV7 plasmid vector
was used to permanently transfect WM35 cells (WM35-p53DN) and cells
transfected with the vector alone (WM35-pCMV7) were generated as
control. All cells were maintained in RPMI 1640 medium supplemented
with 5% fetal bovine serum (both from Gibco/BRL, Gaithersburg, MD)
at 37°C in 7% CO2. To maintain selective growth, transfected cell lines
(WM35-p53DN and WM35-pCMV7) were always supplemented with
medium containing 400 mg per ml geneticin (G418) (Gibco/BRL).
UV irradiation Cells were irradiated in phosphate-buffered saline
(PBS) through the plastic culture dish cover with a solar simulator
(Spectral Energy Corporation, Westwood, NJ), a protocol that exposes
cells to a spectrum of light closely resembling terrestrial sunlight
(Werninghaus et al, 1991). The 1 kW xenon arc lamp (XMN 1000±21;
Optical Radiation, Azuza, CA) irradiance was adjusted to 8 3 10±5 W
per cm2 and metered at 285 6 5 nm with a research radiometer ®tted
with a UVB probe (model IL1700 A; International Light, Newburyport,
MA) (McGregor and Hawk, 1999) to deliver a dose of 10 mJ per cm2.
Sham-irradiated cultures were handled identically, except that they were
shielded with aluminum foil during the irradiation. Cultures were given
fresh medium after irradiation.
Cell growth analysis In order to determine the growth properties of
the melanoma cells, cultures of each melanoma line were plated in
35 mm dishes at a density of 2 3 104 cells per dish. One day later,
duplicate cultures of each line were either irradiated as described above
or sham irradiated. Cells were then given fresh medium and collected
24, 48, and 72 h later for cell number as determined by Coulter
Counter.
PTpT treatment of cultured cells In previous experiments, 100 mM
pTpT consistently elicited UV mimetic responses including
melanogenesis (Eller et al, 1994), induction of tyrosinase mRNA (Eller et
al, 1996), and p53 activation/upregulation (Eller et al, 1997; Goukassian
et al, 1999). Melanoma cells were provided with 100 mM pTpT
(Midland Certi®ed Reagent, Midland, TX) diluted from a 2 mM stock
solution in DME or an equal volume of diluent (DME) alone as control.
PTpT treatment of mouse skin For in vivo experiments, a 2 mM
stock solution of pTpT in H2O was prepared and this stock solution or
an equal volume of diluent as control was added to propylene glycol
(Sigma, St. Louis, MO) to produce a 100 mM solution. C57B1/6 J p53
pro®cient (+/+) as well as C57B1/6 J p53 knockout (±/±) mice, 10±
12 wk of age, were obtained from The Jackson Laboratory (Bar Harbor,
MA). pTpT or diluent control was applied to the right and left ear of
each mouse, respectively, once a day, 5 d per wk, for 3 wk. Three mice
of each genotype were treated. After 3 wk, the animals were euthanized
by inhalation of CO2 and the ears were removed. Four-micron sections
were stained with Fontana Masson and evaluated by microscope. Image
analysis was performed using an Olympus BH-2 light microscope and a
videocamera/computer system (DAGE CCTV, Dage-MTI, Michigan
City, IN, with software by Southern Micro Instruments, Atlanta, GA).
Statistical analysis was performed using the Student's t test.
Western blot analysis Total cellular proteins were collected in a
buffer consisting of 0.25 M Tris±HCl (pH 7.5), 0.375 M NaCl, 2.5%
sodium deoxycholate, 1% Triton X-100, 25 mM MgCl2, 1 mM
phenylmethylsulfonyl ¯uoride, and 0.1 mg per ml aprotinin as described
previously (Yaar et al, 1994). Protein concentration was determined by
the Bradford method and 50 mg of protein per lane was processed for
Western blot analysis as described previously (Yaar et al, 1994). Antibody
reactions were performed with a 1:250 dilution of af®nity puri®ed
mouse monoclonal anti-p53 DO-1 (Ab-6) (Oncogene Science,
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Cambridge, MA). Horseradish-peroxidase-linked sheep antimouse IgG
was obtained from Amersham Life Science, Arlington Heights, IL. The
secondary antibodies were used at 1:2000 dilution. Antibody binding was
detected with the ECL detection kit (Amersham), followed by
autoradiography (Kodak X-Omatic AR ®lm).
Northern blot analysis Total RNA was isolated from cells with Tri-
Reagent (Gibco/BRL) following the protocol of the manufacturer.
RNA concentrations were determined by absorbance at 260 nm. The
ratio of 260/280 was always between 1.8 and 2.0. Fifteen micrograms of
RNA from each sample were electrophoresed on 1% agarose gels
containing 2.2 M formaldehyde as described previously (Yaar et al,
1991). RNA was transferred to nylon membranes (Hybond-N,
Amersham), and immobilized by shortwave UV irradiation (UV-
Stratalinker 1800, Stratagene, La Jolla, CA). Blots were hybridized with
32P-labeled human tyrosinase cDNA (Pmel 34), a kind gift from Dr. B.
Kwon (Guthrie Research Institute, Sayre, PA); p21 cDNA, a kind gift
from Dr. J. Smith (Center on Aging, Baylor College of Medicine,
Houston, TX); and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) cDNA (ATCC #57090) as a loading control.
Densitometric analysis Autoradiographs of Western and northern
blots were scanned (Microtek Scan Maker II) into a computer
(Massachusetts Engineering). Band intensity was determined after
background subtraction using the densitometric program Sigma Gel
(Jandel Scienti®c). Bands of interest were normalized using Coomassie
Blue stained gels (Western blots) or GAPDH band intensity (northern
blots).
Statistical analysis ANOVA with Fisher post hoc analysis was used for
the data in Figs 1 and 3. Repeated measures univariate ANOVA
(Huynh-Feldt) (SPSS version 9) was used for the data shown in Fig 2.
RESULTS
Tyrosinase mRNA and p53 protein in WM35 melanoma
cells To determine the constitutive p53 protein level in these
melanoma cell lines, total cellular proteins were analyzed by
Western blotting, using an antibody that recognizes mutant as well
as wild-type p53 protein (Cohen et al, 1998). Western blot analysis
showed that the constitutive p53 level was approximately twice as
high in cells transfected with the dominant-negative p53 cDNA
than in the parental cell line or cells transfected with the empty
vector (Fig 1A, B). To determine the constitutive level of
tyrosinase mRNA, parental and transfected cell lines were
processed for northern blot analysis. Densitometric analysis
revealed that the tyrosinase mRNA level was higher in the
parental (p < 0.04, ANOVA post hoc analysis by Fisher) and vector-
transfected control cell lines (p < 0.012) than in the WM35-p53DN
cell line that overexpresses p53 (Fig 1C, D) by approximately 2±3-
fold. Thus, in these cells, in agreement with the report of Kichina et
al (1996), tyrosinase mRNA is inversely related to the level of p53
protein.
Regulation of p53 in WM35 melanoma cells by
UV Parental and transfected melanoma cell lines were sham or
UV irradiated and harvested at intervals up to 72 h after irradiation.
Consistent with reports using other cell lines and different UV
doses (Lu and Lane, 1993; Yamaizumi and Sugano, 1994; Medrano
et al, 1995; Maki and Howley, 1997), Western blot analysis showed
an increase in the level of p53 in all irradiated melanoma lines (p
< 0.001) (Fig 2A, B). Compared to baseline, maximal p53
increases of 300% to 400% were observed at 48±72 h after UV
irradiation (Fig 2B). The level of p53 in the sham-irradiated
cultures did not change during this 72 h period.
Induction of tyrosinase mRNA by active p53 Under basal
conditions in normal cells, p53-driven transcriptional activity is low
(Rogel et al, 1995), consistent with the low level of p53 protein
(Oren et al, 1981). Because p53 activation transcriptionally
upregulates the p21 gene (Halaban et al, 1983; Kastan et al, 1992;
el-Deiry et al, 1993; 1995), increased p21 mRNA after UV
irradiation was used as an assessment of p53 activity. Melanoma cell
lines were sham or UV irradiated and p21 gene expression was
analyzed by northern blotting. WM35 and WM35-pCMV7 cells
expressing functional p53 approximately tripled their p21 mRNA
levels as early as 24 h after UV irradiation and the increases persisted
through 72 h, but there was no increase in the low baseline level of
p21 mRNA in the WM35-p53DN cells, further demonstrating the
p53DN phenotype of these cells (Fig 3A, B). These results are
consistent with active p53 being necessary for p21 induction but
not for constitutive expression, as previously shown in p53-null
cells transfected with wild-type p53 or an empty vector control
construct (Eller et al, 1997).
In order to determine the effect of p53 activation following UV
irradiation on tyrosinase mRNA expression, northern blots of the
melanoma lines were rehybridized with the tyrosinase probe. As
previously reported for either single or multiple exposures in
Cloudman S91 melanoma cells and human melanocytes (Aberdam
et al, 1993; Eller et al, 1996), UV irradiation led to an initial
decrease of 25%±50% in tyrosinase mRNA levels 24 h after
irradiation (Fig 3C, D). In melanoma lines expressing activated
p53 as determined by the UV-induced transactivation of the p21
gene, however, thereafter there was a progressive increase in
tyrosinase mRNA after irradiation, to approximately 250% to 350%
of baseline levels at 48 and 72 h, respectively (p < 0.05 at both
Figure 1. Relationship between p53 and
tyrosinase mRNA in WM35 melanoma cells.
Duplicate cultures of parental and transfected
melanoma cells were plated at a density of
50 3 103 cells in 60 mm dishes and at near
con¯uence (day 7) were harvested and processed
for (A) Western and (C) northern blot analyses.
The Western blot membrane was reacted with an
anti-p53 antibody (DO-1), and the northern blot
was sequentially hybridized with cDNAs for
tyrosinase and GAPDH (as a loading control).
The ethidium-bromide-stained gel is also shown
verifying even loading. The Western and northern
blot analyses derive from paired dishes of the same
experiment so that relative p53 protein levels and
tyrosinase mRNA levels can be directly compared
among the different cell lines. Densitometric
analyses are for two Western blots (B) and three
northern blots (D), of which (A) and (C) are
representative. For both Western and northern
blots, the densitometric value for the p53DN cell
line was set at 100% and the other cell lines are
represented as a percentage of that value. Measure
of variance in (B) is standard deviation (SD) and
in (D) is standard error (SE) of the mean.
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times, ANOVA post hoc analysis by Fisher). In contrast, in the
p53DN cells, no delayed increase in tyrosinase mRNA was
observed.
In normal cells, UV irradiation leads to growth arrest (el-
Deiry et al, 1995), and decreased proliferative rate per se may be
associated with a more differentiated phenotype. In order to
exclude the possibility that increased tyrosinase expression in
cells expressing wild-type p53 versus dominant-negative p53 was
a nonspeci®c consequence of altered proliferative rate, growth
curves were determined for the three cell lines. In all lines,
sham-irradiated cultures grew more rapidly than paired UV-
irradiated cultures, as expected. The p53DN-transfected cells
grew more slowly than controls, however, displaying a doubling
time of approximately 36 h versus 24 h for controls, excluding
more rapid proliferation as an explanation for their reduced
tyrosinase expression.
Induction of tyrosinase mRNA by pTpT in WM35
melanoma cells Previous work in our laboratory has shown
that pTpT evokes a variety of photoprotective responses in large
part, if not exclusively, by upregulation and activation of p53 (Eller
et al, 1997; Goukassian et al, 1999; Maeda et al, 1999). pTpT
treatment also leads to delayed increases in tyrosinase mRNA and
pigmentation in human melanocytes and S91 Cloudman melanoma
cells (Eller et al, 1994, 1996). To further con®rm that activated p53
induces tyrosinase mRNA expression, and to avoid the
complication of the membrane-associated pathways stimulated by
UV irradiation that can affect transcription, the parental cells
expressing wild-type p53 and p53DN-transfected cells were
stimulated with 100 mM pTpT and processed for northern
blotting. At 24 and 72 h after pTpT supplementation, the
tyrosinase mRNA level doubled in the WM35 melanoma cells
that express wild-type activatable p53, whereas tyrosinase mRNA
levels remained unchanged in WM35-p53DN cells (Fig 4A, B),
con®rming that activation of p53 is required for tyrosinase mRNA
upregulation by pTpT.
Induction of melanogenesis by pTpT in vivo We have
previously shown that pTpT induces melanogenesis in intact skin,
at least in part through increasing tyrosinase mRNA and protein
levels (Eller et al, 1994). In order to examine the role of p53 in this
in vivo response, but avoiding the known effects of UV irradiation
on cell membranes and on melanocyte proliferation (Gilchrest et al,
1998), p53 wild-type (+/+) and p53 knockout (±/±) mice were
treated with pTpT and the pigmentation response was compared.
Three weeks of ®ve times per week application of pTpT to p53
pro®cient mice produced a 10-fold increase in epidermal melanin
content as determined by confocal microscopy and image analysis
(Fig 5A). In contrast, no increase in epidermal melanin content
was detected in the p53 (±/±) mice (Fig 5A, B). As previously
reported (Quevedo et al, 1966), there were very few or no
melanocytes in murine epidermis, and none were detected by
routine histology or by immunostaining for TRP-1 (Mel-5) in
either pTpT-treated or vehicle-treated skin (data not shown). This
fact, in combination with the growth inhibition rather than the
Figure 2. Effect of UV irradiation on p53 levels. Melanoma cell
lines were irradiated with a physiologic dose of solar-simulated light or
were sham irradiated, as described in Materials and Methods. (A) Total
cellular proteins were collected at time 0 and at intervals up to 72 h after
UV irradiation, and 50 mg of protein from each sample were processed
for Western blot analysis with an anti-p53 antibody (DO-1). Three
different blots are shown, so that quantitative comparison for p53 cannot
be made among them. Protein loading was normalized using the mean
densitometric intensity for two representative bands (shown) from the
Coomassie blue-stained gel in which virtually all visible protein bands
showed comparable variability among lanes. (B) Densitometric analysis
showed that, after UV irradiation, p53 protein levels comparably
increased in all melanoma cell lines through 72 h. Time 0 values for
each cell line were set at 100% and values for all time points were
expressed as a percentage of this value. All sham-irradiated values were
610% of the time 0 values. In all histograms, SE is the measure of
variance.
Figure 3. UV induction of p21 and
tyrosinase mRNA by p53. Melanoma cell lines
were UV irradiated as described in Materials and
Methods. Cells were collected at time 0 and at
intervals up to 72 h after irradiation and were
processed for northern blot analysis with
sequential hybridization using cDNA probes
speci®c for p21 (A), tyrosinase (C), and GAPDH
(loading control), followed by densitometric
analysis. Note that samples from all melanoma
lines were processed together in one gel, so that
p21, tyrosinase, and GAPDH mRNA levels can
be directly compared among them. Time 0 for
each cell line was set at 100% and all time points
were calculated as a percentage of this value for
two separate experiments for p21 (B) and three
separate experiments for tyrosinase (D). In the
histogram, the measure of variance for p21 is SD
and for tyrosinase is SE.
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stimulation observed after pTpT treatment of cultured cells (Eller et
al, 1996), strongly suggests that the increased melanin content in
pTpT-treated p53 +/+ murine skin is fully attributable to increased
tyrosinase mRNA and protein levels, as in vitro (Eller et al, 1994),
rather than to an increased number of melanocytes; and that the
lack of melanin increase in pTpT-treated p53 ±/± murine skin is
due to lack of p53 upregulation of tyrosinase gene expression.
DISCUSSION
Tyrosinase is the rate-limiting enzyme for production of melanin
(Hearing and JimeÂnez, 1989), a brown-black polymer that protects
against UV-induced damage (Noda et al, 1993) by absorbing the
UV photons and UV-induced free radicals before they can interact
with cellular constituents (McGregor and Hawk, 1999). Both
Figure 4. p53 requirement for pTpT-
induced tyrosinase mRNA in vitro. Parental
WM35 cells expressing wild-type p53 (p53wt) and
cells transfected with dominant-negative p53
(p53DN) were supplemented with 100 mM pTpT.
Cells were collected at time 0, 24, and 72 h after
pTpT addition and total RNA was processed for
northern blot analysis (A) as detailed in Fig 1
legend. (B) Densitometric analysis was performed.
Time 0 values for each cell line were set at 100%
and other time points were calculated as a
percentage of this value. In the histogram the
measure of variance is SD.
Figure 5. p53 requirement for pTpT-
induced melanogenesis in vivo. Three p53
(+/+) and three knockout (±/±) mice were
treated daily for 3 wk with 100 mM pTpT on
one ear and propylene glycol as a diluent control
on the other. Ear sections were stained with
Fontana Masson to highlight melanin and then
observed by confocal microscopy. Representative
cross-sections of epidermis (A). The epidermal
melanin content was determined by image
analysis as described in Materials and Methods and
graphed as mean 6 SE (B).
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tyrosinase activity and melanin content of skin increase 3±5 d after
suf®cient sun exposure (Kostanecki et al, 1976), a phenomenon
termed delayed tanning. Of note, X-irradiation and certain DNA-
damaging chemotherapeutic agents also induce tanning-like
hyperpigmentation (Gilchrest and Eller, 1999).
Regulation of tyrosinase activity is complex but appears to occur
in part at the level of gene transcription. The promoter of the
human tyrosinase gene has been sequenced, and the potential
regions regulating tyrosinase gene expression were determined by
transient transfection with a CAT readout gene driven by tyrosinase
promoters with various deletions (Ponnazhagan et al, 1994).
Sequence analysis of the 2 kbp tyrosinase promoter revealed a
TATA box 27 bp upstream from the transcription start site and a
CAAT box 128 bp upstream. In addition, there were ®ve putative
AP-1 and two AP-2 sites, two glucocorticoid-responsive elements,
three Oct-1 sites, and two UV-responsive elements. In addition,
the tyrosinase promoter contains an ``M box'', a conserved element
found in many melanocyte-speci®c genes and a known binding site
for the microphthalmia-associated transcription factor (MITF),
known to activate transcription of the tyrosinase gene (Bentley et al,
1994; Yasumoto et al, 1994). MITF can be induced by cAMP
(Price et al, 1998), which can increase tyrosinase mRNA levels
(Halaban et al, 1984). It is not known whether p53 regulates MITF
expression but no p53 consensus sequence has been identi®ed in
the MITF promoter. Deletion mutations of the tyrosinase promoter
region have shown that regions as small as 550 bp are active, albeit
less than the full-length promoter (Ponnazhagan et al, 1994),
suggesting that tyrosinase gene transcription is controlled by
multiple regulatory elements, which in turn may be activated by
different factors.
Our study establishes that high levels of p53 protein down-
regulate tyrosinase mRNA, whereas transcriptionally active p53
upregulates tyrosinase mRNA. The lack of an identi®ed p53
consensus sequence in the tyrosinase promoter (Bargonnetti et al,
1991) suggests that this regulation is indirect. For example, the
initial downregulation of tyrosinase mRNA following p53
transfection of melanoma cells (Kichina et al, 1996) may result
from p53 binding to the TATA-binding protein (Kern et al, 1991;
Aoyama et al, 1992; Seto et al, 1992; Mack et al, 1993; Park et al,
1996), reducing the basal transcription rate; whereas the delayed
tyrosinase upregulation may result from induction of one or more
intermediary gene products by p53. Our data in a human
melanoma line and in murine melanocytes in vivo validate the
conclusions of Nylander et al (2000) in Saos-2 cells that p53
activation upregulates tyrosinase by demonstrating that this p53
effect is not an artifact of working with a nonmelanocyte cell line
that might possibly express irrelevant p53-regulated gene products
capable of modifying tyrosinase expression.
Regardless of the precise molecular mechanisms, our data
demonstrate that p53 protein negatively regulates tyrosinase gene
transcription, whereas activation of p53 increases tyrosinase mRNA
level. Our results further demonstrate the essential role of p53 even
in intact skin in the induction of pigmentation by pTpT, selected as
the test agent because it appears to act by mimicking DNA damage
speci®cally (Gilchrest and Eller, 1999), in contrast to UV irradiation
that clearly activates cell membrane-associated signal transduction
pathways (Rosette and Karin, 1996; Gilchrest et al, 1998) as well as
nuclear pathways involving p53. In the context of previous studies
(Eller et al, 1994; 1996; 1997; Goukassian et al, 1999), these data
suggest that tanning should now be included in the broad array of
DNA damage-induced p53-mediated adaptive differentiation
responses that protect mammalian cells during subsequent exposure
to DNA-damaging agents such as UV irradiation.
REFERENCES
Abdel-Malek Z, Swope VB, Suzuki I, et al: Mitogenic and melanogenic stimulation
of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci
USA 92:1789±1793, 1995
Aberdam E, Romero C, Ortonne JP: Repeated UVB irradiations do not have the
same potential to promote stimulation of melanogenesis in cultured normal
human melanocytes. J Cell Sci 106:1015±1022, 1993
Agoff SN, Hou J, Linzer DI, Wu B: Regulation of the human hsp70 promoter by
p53. Science 259:84±87, 1993
Allan AE, Archambault M, Messana E, Gilchrest BA: Topically applied
diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol
105:687±692, 1995
Aoyama N, Nagase T, Sawazaki T, et al: Overlap of the p53-responsive element and
cAMP-responsive element in the enhancer of human T-cell leukemia virus
type I. Proc Natl Acad Sci USA 89:5403±5407, 1992
Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human
colorectal carcinoma cell growth by wild-type p53. Science 249:912±915, 1990
Bargonnetti J, Friedman PN, Kern SE, Vogelstein B, Prives C: Wild-type but not
mutant p53 immunopuri®ed proteins bind to sequences adjacent to the SV40
origin of replication. Cell 65:1083±1091, 1991
Bentley NJ, Eisen T, Goding CR: Melanocyte-speci®c expression of the human
tyrosinase promoter: activation by the microphthalmia gene product and role of
the initiator. Mol Cell Biol 14:7996±8006, 1994
Bolognia J, Murray M, Pawelek J: UVB-induced melanogenesis may be mediated
through the MSH-receptor system. J Invest Dermatol 92:651±656, 1989
Cohen PA, Mani JC, Lane DP: Characterization of new intrabody directed against
the N-terminal region of human p53. Oncogene 17:2445±2456, 1998
Cornil I, Theodorescu D, Man S, Herlin M, Jambrosic J, Kerbel RS: Fibroblast cell
interactions with human melanoma cells affect tumor cell growth as a function
of tumor progression. Proc Natl Acad Sci USA 88:6028±6032, 1991
el-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53
tumor suppression. Cell 75:817±825, 1993
el-Deiry WS, Tokino T, Waldman T, et al: Topological control of p21WAF1/CIP1
expression in normal and neoplastic tissues. Cancer Res 55:2910±2919, 1995
Eller MS, Yaar M, Gilchrest BA: DNA damage and melanogenesis. Nature 372:413±
411, 1994
Eller MS, Ostrom K, Gilchrest BA: DNA damage enhances melanogenesis. Proc Natl
Acad Sci USA 93:1087±1092, 1996
Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA: Enhancement of DNA
repair in human skin cells by thymidine dinucleotides: evidence for a p53-
mediated mammalian SOS response. Proc Natl Acad Sci USA 94:12627±12632,
1997
Farmer G, Bargonetti J, Zhu H, Friedman P, Prives C: Wild-type p53 activates
transcription in vitro. Nature 358:83±86, 1992
Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53
protein. Science 249:1046±1049, 1992
Florenes VA, Bhattacharya N, Bani MR, Ben-david Y, Kerbel RS, Slingerland JM:
TGF-beta mediated G1 arrest in a human melanoma cell line lacking
p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27/
Kip1. Oncogene 13:2447±2457, 1996
Friedmann PS, Gilchrest BA: Ultraviolet radiation directly induces pigment
production by cultured human melanocytes. J Cell Physiol 133:88±94, 1987
Fuller BB, Lunsford JB, Iman DS: Alpha-melanocyte-stimulating hormone
regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. J
Biol Chem 262:4024±4033, 1987
Gilchrest BA, Eller MS: DNA photodamage stimulates melanogenesis and other
photoprotective responses. J Invest Dermatol Symp Proc 4:35±40, 1999
Gilchrest BA, Zhai S, Eller MS, Yarosh DB, Yaar M: Treatment of human
melanocytes and S91 melanoma cells with the DNA repair enzyme T4
endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest
Dermatol 101:666±672, 1993
Gilchrest BA, Park HY, Eller MS, Yaar M: The photobiology of the tanning
response. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP
(eds.), Pigmentary System: Physiology and Pathophysiology. New York: Oxford
University Press, 1998:pp 359±373
Gordon PR, Gilchrest BA: Human melanogenesis is stimulated by diacylglycerol. J
Invest Dermatol 93:700±702, 1989
Goukassian DA, Eller MS, Yaar M, Gilchrest BA: Thymidine dinucleotide mimics
the effect of solar simulated irradiation on p53-regulated proteins. J Invest
Dermatol 112:25±31, 1999
Hadshiew IM, Eller MS, Gasparro FP, Gilchrest BA: Stimulation of melanogenesis by
DNA oligonucleotides: effect of size, sequence and 5¢ phosphorylation. J
Dermatol Sci 25:127±138, 2001
Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB: Regulation of
tyrosinase in human melanocytes grown in culture. J Cell Biol 97:480±488,
1983
Halaban R, Pomerantz S, Marshall S, Lerner AB: Tyrosinase activity and abundance
in Cloudman melanoma cells. Arch Biochem Biophys 230:383±387, 1984
Hearing VJ, JimeÂnez M: Analysis of pigmentation at the molecular level. Pigment Cell
Res 2:75±80, 1989
Hupp TR, Meek DW, Midgley CA, Lane DP: Regulation of the speci®c DNA
binding function of p53. Cell 71:875±886, 1992
Kastan MB, Zhan Q, el-Deiry WS, et al: A mammalian cell cycle checkpoint pathway
utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587±
597, 1992
Kern SE, Kinzle KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B:
Identi®cation of p53 as a sequence-speci®c DNA-binding protein. Science
252:1708±1711, 1991
Kichina J, Green A, Rauth S: Tumor suppressor p53 down-regulates tissue-speci®c
expression of tyrosinase gene in human melanoma cell lines. Pigment Cell Res
9:85±91, 1996
VOL. 118, NO. 1 JANUARY 2002 TYROSINASE IS REGULATED BY P53 131
Kley N, Chung RY, Fay S, Loef¯er JP, Seizinger BR: Repression of the basal c-fos
promoter by wild-type p53. Nucl Acids Res 20:4083±4087, 1992
Kostanecki W, Radwan I, Mroczkowski T: The effect of X-ray irradiation upon the
epithelial melanin unit of the hair bulb in hooded rat. Arch Dermatol Res
256:297±303, 1976
Lane DP: Cancer: p53, guardian of the genome. Nature 358:15±16, 1992
Li ZH, Zhu YJ, Lit XT: Wild-type p53 gene increases MDR1 gene expression but
decreases drug resistance in an MDR cell line KBV2000. Cancer Lett 119:177±
184, 1997
Lu X, Lane DP: Differential induction of transcriptionally active p53 following UV
or ionizing radiation: defects in chromosome instability syndromes? Cell
75:765±778, 1993
Mack DH, Vartikar J, Pipas JM, Laimins LA: Speci®c repression of TATA-mediated
but not initiator-mediated transcription by wild-type p53. Nature 363:281±283,
1993
Maeda T, Eller MS, Hedayati M, Grossman L, Gilchrest BA: Enhanced repair of
benzo(a)pyrene-induced DNA damage in human cells treated with thymidine
dinucleotides. Mutat Res 433:137±145, 1999
Maki CG, Howley PM: Ubiquitination of p53 and p21 is differentially affected by
ionizing and UV radiation. Mol Cell Biol 17:355±363, 1997
Martin DW, Munoz RM, Subler MA, Deb S: p53 binds to the TATA-binding
protein-TATA complex. J Biol Chem 268:13062±13067, 1993
McGregor JM, Hawk JLM: Acute effects of ultraviolet radiation on the skin. In:
Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith LA, Katz SI,
Fitzpatrick TB (eds.), Fitzpatrick's Dermatology in General Medicine: Acute Effects
of Ultraviolet Radiation on the Skin. McGraw-Hill, 1999:pp 1555±1561
Medrano EE, Im S, Yang F, Abdel-Malek ZA: Ultraviolet B light induces G1 arrest
in human melanocytes by prolonged inhibition of retinoblastoma protein
phosphorylation associated with long-term expression of the p21Waf-1/SDI-
1/CIP-1 protein. Cancer Res 55:4047±4052, 1995
Moberg KH, Tyndall WA, Hall HJ: Wild-type murine p53 represses transcription
from the murine c-myc promoter in a human glial cell line. J Cell Biochem
49:208±215, 1992
Morris GF, Bischoff JR, Mathews MB: Transcriptional activation of the human
proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci USA
93:895±899, 1996
Noda T, Kawada A, Hiruma M, Ishibashi A, Arai S: A new approach to the
evaluation of broad-spectrum sunscreens against ultraviolet and visible light-
induced delayed tanning. J Dermatol 20:540±544, 1993
Nylander K, Bourdon JC, Bray SE, Gibbs NK, Kay R, Hart I, Hall PA:
Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation
to the protective tanning response. J Pathol 190:39±46, 2000
Oren M, Maltzman W, Levine AJ: Post-translational regulation of the 54K cellular
tumor antigen in normal and transformed cells. Mol Cell Biol 1:101±110, 1981
Park HY, Russakovsky V, Ohno S, Gilchrest BA: The beta isoform of protein kinase
C stimulates human melanogenesis by activating tyrosinase in pigment cells. J
Biol Chem 268:11742±11749, 1993
Park HY, Russakovsky V, Ao Y, Fernandez E, Gilchrest BA: Alpha-melanocyte
stimulating hormone-induced pigmentation is blocked by depletion of protein
kinase C. Exp Cell Res 227:70±79, 1996
Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA: Protein kinase C-beta
activates tyrosinase by phosphorylating serine residues in its cytoplasmic
domain. J Biol Chem 274:16470±16478, 1999
Pawelek JM, Sansone M, Koch N, et al: Melanoma cells resistant to inhibition of
growth by melanocyte stimulating hormone. Proc Natl Acad Sci USA 72:951±
955, 1975
Ponnazhagan S, Hou L, Kwon BS: Structural organization of the human tyrosinase
gene and sequence analysis and characterization of its promoter region. J Invest
Dermatol 102:744±748, 1994
Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM, Landis
MW, Fisher DE: a-melanocyte-stimulating hormone signaling regulates
expression of microphthalmia, a gene de®cient in Waardenburg syndrome. J
Biol Chem 273:33042±33047, 1998
Quevedo WC, Youle MC, Tovee DT, Bienieki TC: The developmental fate of
melanocytes in murine skin. In: Della Porta G, Muhlbock O (eds.) Structure and
Control of the Melanocyte. New York: Springer-Verlag, 1966: pp 228±241
Ranson M, Posen S, Mason RS: Human melanocytes as a target tissue for hormones:
in vitro studies with 1 alpha-25, dihydroxyvitamin D3, alpha-melanocyte
stimulating hormone, and beta-estradiol. J Invest Dermatol 91:593±598, 1988
Rogel A, Popliker M, Webb CG, Oren M: p53 cellular tumor antigen: analysis of
mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol
5:2851±2855, 1995
Rolley N, Butcher S, Milner J: Speci®c DNA binding by different classes of human
p53 mutants. Oncogene 11:763±770, 1995
Rosette C, Karin M: Ultraviolet light and osmotic stress: activation of the JNK
cascade through multiple growth factor and cytokine receptors. Science
274:1194±1197, 1996
Santhanam U, Ray A, Sehgal PB: Repression of the interleukin 6 gene promoter by
p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA
88:7605±7609, 1991
Seto E, Usheva A, Zambetti GP, et al: Wild-type p53 binds to the TATA-binding
protein and represses transcription. Proc Natl Acad Sci 89:12028±12032, 1992
Shivakumar CV, Brown DR, Deb S, Deb SP: Wild-type human p53 transactivates
the human proliferating cell nuclear antigen promoter. Mol Cell Biol 15:6785±
6793, 1995
Werninghaus K, Handjani RM, Gilchrest BA: Protective effect of alpha-tocopherol
in carrier liposomes on ultraviolet-mediated human epidermal cell damage
in vitro. Photodermatol Photoimmunol Photomed 8:236±242, 1991
Wong G, Pawelek J: Melanocyte-stimulating hormone promotes activation of pre-
existing tyrosinase molecules in Cloudman S91 melanoma cells. Nature
255:644±646, 1975
Wu X, Bayle JH, Olson D, Levine AJ: The p53-mdm-2 autoregulatory feedback
loop. Genes Dev 7:1126±1132, 1993
Yaar M, Grossman K, Eller M, Gilchrest BA: Evidence for nerve growth factor-
mediated paracrine effects in human epidermis. J Cell Biol 115:821±828, 1991
Yaar M, Eller MS, DiBenedetto P, et al: The trk family of receptors mediates nerve
growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 94:1550±
1562, 1994
Yamaguchi M, Hayashi Y, Matsuoka S, Takahashi T, Matsukage A: Differential
effect of p53 on the promoters of mouse DNA polymerase beta gene and
proliferating-cell-nuclear-antigen gene. Eur J Biochem 221:227±237, 1994
Yamaizumi M, Sugano T: UV-induced nuclear accumulation of p53 is evoked
through DNA damage of actively transcribed genes independent of the cell
cycle. Oncogene 9:2775±2784, 1994
Yasumoto KI, Yokoyama K, Shibata K, Tomita Y, Shibahara S: Microphthalmia-
associated transcription factor as a regulator for melanocyte-speci®c
transcription of the human tyrosinase gene. Mol Cell Biol 14:8058±8070, 1994
Zhan Q, Carrier F, Fornace A Jr: Induction of cellular p53 activity by DNA-
damaging agents and growth arrest. Mol Cell Biol 7:4242±4250, 1993
132 KHLGATIAN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
